Addressing HIV in an often ‘invisible’ population
One of the challenges in reducing the number of children living with HIV is that they are often difficult to find, they are spread out and they may not know they have the infection. Children also don’t have a voice to share their treatment concerns, ambitions or express what they want and need for their care. They are often overlooked and can become ‘invisible’.
Currently, there are few child-friendly HIV treatments, making it even more difficult for children living with HIV to live happily and healthily, as they deserve to. It is vital that we address the gaps in paediatric HIV treatment and work to develop innovative, age appropriate formulations.
We have voluntary licence agreements in place which cover areas where 99% of children living with HIV in the developing world reside3 , meaning generic companies can develop, make and sell generic versions of dolutegravir.